Azadeh Jafrasteh
Research Subjects
Research Interests
Azadeh Jafrasteh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Abdollah Karimi
Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications - Seyedeh Mahsan Hoseini-Alfatemi
Pediatric Infections Research Center, Research Institute for Children’s Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Ali Pajouhi
Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication - Alireza Fahimzad
Pediatric Infectious Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication Amir Mohammad Karimi
Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication- Amirata Fakhfouri
Iranian Research Center for HIV/AIDS Tehran University of Medical Sciences Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (11)
Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study
Background and Aims: Multisystem inflammatory syndrome in children (MIS‐C) is a post‐infectious inflammatory condition associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that can affect multiple organ systems. Data comparing clinical features and outcomes between MIS‐C patients with and without laboratory evidence of coronavirus disease 2019 (COVID‐19) remain limited. Methods: This retrospective observational study was conducted at Mofid Children's Hospital, a pediatric referral center in Tehran, Iran, between March 2020 and July 2021. Children diagnosed with MIS‐C based on World Health Organization (WHO) criteria were included and classified into groups with and without laboratory evidence of SARS‐CoV‐2 infection according to PCR and/or IgG serology results. Demographic data, clinical manifestations, laboratory and imaging findings, treatments, and outcomes were compared between the groups using univariate and multivariable analyses. A p ‐value < 0.05 was considered statistically significant. Results: A total of 121 patients with MIS‐C were included, of whom 44 (36.4%) had laboratory evidence of SARS‐CoV‐2 infection. The mean age was 4.74 ± 3.99 years, and 61.2% were male. ICU admission occurred in 21.5% and mortality was 2.5%. In univariate analysis, fever during the first 24 h of hospitalization and antiviral use were more frequent in the group with laboratory evidence, whereas conjunctivitis and elevated C‐reactive protein levels were more common among the group without laboratory evidence; however, CRP did not differ significantly between groups when analyzed as a continuous variable. In multivariable analysis, fever during the first 24 h of hospitalization was the only variable associated with laboratory evidence of SARS‐CoV‐2 infection (aOR 2.57; 95% CI 1.05–6.30; p = 0.040). Conclusion: MIS‐C presents with broad and largely overlapping clinical, laboratory, and imaging features regardless of SARS‐CoV‐2 laboratory status, and the few observed differences were exploratory and of limited discriminative value. These findings highlight the importance of considering MIS‐C even in the absence of laboratory confirmation of SARS‐CoV‐2 infection.
- 5 November 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (11)
Open AccessClinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study
Background and Aims: Multisystem inflammatory syndrome in children (MIS‐C) is a post‐infectious inflammatory condition associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that can affect multiple organ systems. Data comparing clinical features and outcomes between MIS‐C patients with and without laboratory evidence of coronavirus disease 2019 (COVID‐19) remain limited. Methods: This retrospective observational study was conducted at Mofid Children's Hospital, a pediatric referral center in Tehran, Iran, between March 2020 and July 2021. Children diagnosed with MIS‐C based on World Health Organization (WHO) criteria were included and classified into groups with and without laboratory evidence of SARS‐CoV‐2 infection according to PCR and/or IgG serology results. Demographic data, clinical manifestations, laboratory and imaging findings, treatments, and outcomes were compared between the groups using univariate and multivariable analyses. A p ‐value < 0.05 was considered statistically significant. Results: A total of 121 patients with MIS‐C were included, of whom 44 (36.4%) had laboratory evidence of SARS‐CoV‐2 infection. The mean age was 4.74 ± 3.99 years, and 61.2% were male. ICU admission occurred in 21.5% and mortality was 2.5%. In univariate analysis, fever during the first 24 h of hospitalization and antiviral use were more frequent in the group with laboratory evidence, whereas conjunctivitis and elevated C‐reactive protein levels were more common among the group without laboratory evidence; however, CRP did not differ significantly between groups when analyzed as a continuous variable. In multivariable analysis, fever during the first 24 h of hospitalization was the only variable associated with laboratory evidence of SARS‐CoV‐2 infection (aOR 2.57; 95% CI 1.05–6.30; p = 0.040). Conclusion: MIS‐C presents with broad and largely overlapping clinical, laboratory, and imaging features regardless of SARS‐CoV‐2 laboratory status, and the few observed differences were exploratory and of limited discriminative value. These findings highlight the importance of considering MIS‐C even in the absence of laboratory confirmation of SARS‐CoV‐2 infection.
- Open Access
- 1 January 2025
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2025 (1)
Knowledge, Attitude, and Performance Among First High School Students in the Prevention of COVID‐19 in Schools of Khorramabad City in 2022
Background: The purpose of this study was to investigate the knowledge, attitude, and performance of the first secondary‐level students in preventing COVID‐19 in the schools of Khorramabad in 2022. Methods: In our study, the information, knowledge, attitude, and performance of 370 first‐grade secondary school students were recorded using a standard questionnaire. Data were analyzed using SPSS Version 26 software and descriptive statistical methods (mean and standard deviation) and appropriate inferential tests to compare groups and examine the correlation between knowledge, attitude, and performance. Findings: The average score of knowledge, attitude, and performance was 59.11 ± 20.51, 81.25 ± 13.68, and 65.4 ± 23.1. The average score of knowledge in students over 14 years of age, ninth‐grade students and good academic status, the score of knowledge and attitude of students with mothers with university education, and finally, the average score of knowledge, attitude, and performance of students with underlying disease were significantly higher than other students. Also, knowledge had a direct and significant relationship with attitude and performance. In addition, attitude and performance also had a direct and significant relationship. Conclusion: The level of knowledge of the people was average, and attitude and performance were positive. Based on the importance of performance, people’s attitude towards COVID‐19 should be improved, because knowledge alone cannot improve people’s performance.
- 1 January 2025
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2025 (1)
Open AccessKnowledge, Attitude, and Performance Among First High School Students in the Prevention of COVID‐19 in Schools of Khorramabad City in 2022
Background: The purpose of this study was to investigate the knowledge, attitude, and performance of the first secondary‐level students in preventing COVID‐19 in the schools of Khorramabad in 2022. Methods: In our study, the information, knowledge, attitude, and performance of 370 first‐grade secondary school students were recorded using a standard questionnaire. Data were analyzed using SPSS Version 26 software and descriptive statistical methods (mean and standard deviation) and appropriate inferential tests to compare groups and examine the correlation between knowledge, attitude, and performance. Findings: The average score of knowledge, attitude, and performance was 59.11 ± 20.51, 81.25 ± 13.68, and 65.4 ± 23.1. The average score of knowledge in students over 14 years of age, ninth‐grade students and good academic status, the score of knowledge and attitude of students with mothers with university education, and finally, the average score of knowledge, attitude, and performance of students with underlying disease were significantly higher than other students. Also, knowledge had a direct and significant relationship with attitude and performance. In addition, attitude and performance also had a direct and significant relationship. Conclusion: The level of knowledge of the people was average, and attitude and performance were positive. Based on the importance of performance, people’s attitude towards COVID‐19 should be improved, because knowledge alone cannot improve people’s performance.
- Open Access
- 15 December 2021
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2021, 1-5
Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics
Background. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts of the world, including Iran. Thus, this study aims to evaluate the epidemiological features, laboratory and imaging findings, and the type of treatments in children with novel coronavirus 2019 (COVID-19). Method. This study is conducted from March 2020March 2021 by using the medical records of hospitalized confirmed COVID-19 children younger than 18 years in five cities of Iran: Tehran, Ahwaz, Isfahan, Bandar-Abbas, and Khorramabad. In addition to demographic and epidemiological data, we also studied clinical signs and treatments. Results. In total 278 confirmed COVID-19 children, the average age was 5.3 years, and 59.4were boys. A total of 37.8 had an underlying disease, in which the most common was a malignancy. The most common symptoms were fever and cough. In this group of pediatrics, some abnormal laboratory findings have been seen. GGO (Ground-Glass Opacity) had been diagnosed in 58.6 of children. 3.6 needed oxygen therapy with ventilators, and 83.09 had received antibiotic treatments with the majority of ceftriaxone. Also, 10 had got steroids. In this study, the mortality rate was 4.3. Conclusion. In this study, most of the children who died had an underlying disease, so timely care and action is important in them. Most children admitted to our study received antibiotics and were prescribed antivirals and steroids for a smaller number. Also, a small number of children received oxygen therapy, most of whom were in the age group of 1 to 5 years.
- 15 December 2021
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2021, 1-5
Open AccessIranian Pediatric COVID-19 Epidemiology and Clinical Characteristics
Background. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts of the world, including Iran. Thus, this study aims to evaluate the epidemiological features, laboratory and imaging findings, and the type of treatments in children with novel coronavirus 2019 (COVID-19). Method. This study is conducted from March 2020March 2021 by using the medical records of hospitalized confirmed COVID-19 children younger than 18 years in five cities of Iran: Tehran, Ahwaz, Isfahan, Bandar-Abbas, and Khorramabad. In addition to demographic and epidemiological data, we also studied clinical signs and treatments. Results. In total 278 confirmed COVID-19 children, the average age was 5.3 years, and 59.4were boys. A total of 37.8 had an underlying disease, in which the most common was a malignancy. The most common symptoms were fever and cough. In this group of pediatrics, some abnormal laboratory findings have been seen. GGO (Ground-Glass Opacity) had been diagnosed in 58.6 of children. 3.6 needed oxygen therapy with ventilators, and 83.09 had received antibiotic treatments with the majority of ceftriaxone. Also, 10 had got steroids. In this study, the mortality rate was 4.3. Conclusion. In this study, most of the children who died had an underlying disease, so timely care and action is important in them. Most children admitted to our study received antibiotics and were prescribed antivirals and steroids for a smaller number. Also, a small number of children received oxygen therapy, most of whom were in the age group of 1 to 5 years.